The NVX-CoV2373 COVID-19 vaccine offers significant protection against symptomatic infections, but its effectiveness against SARS-CoV-2 declines within four months, according to a study in JAMA Network Open using Italian data. However, its protection against symptomatic COVID-19 seems to remain stable during this period.
Sernova says five diabetes patients have now been taken off insulin after ‘cell pouch’ therapy
Five patients with type 1 diabetes have stopped taking insulin after getting Sernova’s cell transplant treatment, the Canadian biotech reported Monday morning. It’s the latest
June 27, 2023